Patents by Inventor Christopher K. Cook

Christopher K. Cook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240106303
    Abstract: Systems and methods for electric motor cooling. The cooling system, in one example, includes a sealing ring coupled to or formed in a stator and including a flange that axially extends outward from an axial side of the stator. The cooling system further includes a first sealing sleeve with a first sealing interface that is formed between the sealing sleeve and a motor housing and a second sealing interface that is formed between the sealing sleeve and the flange, where a cavity is formed between the sealing sleeve and the sealing ring in which a stator end winding is at least partially immersed in a coolant.
    Type: Application
    Filed: September 22, 2023
    Publication date: March 28, 2024
    Inventors: Matthew K. PASCHALL, Samuel Wesley COX, Carl TRUDEL, Alexandre PARE, Steven VANHEE, Luke MILLER, Christopher M. COOK
  • Publication number: 20040019918
    Abstract: Isolated nucleic acid molecules encoding human MEKK2, and isolated human MEKK2 proteins, are provided. The invention further provides antisense nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals carrying a human MEKK2 transgene. The invention further provides human MEKK2 fusion proteins and anti-human MEKK2 antibodies. Methods of using the human MEKK2 proteins and nucleic acid molecules of the invention are also disclosed, including methods for detecting human MEKK2 activity in a biological sample, methods of modulating human MEKK2 activity in a cell, and methods for identifying agents that modulate the activity of human MEKK2.
    Type: Application
    Filed: June 5, 2003
    Publication date: January 29, 2004
    Applicant: AtheroGenics, Inc.
    Inventors: Anne M. Whalen, Christopher K. Cook, James A. Sikorski
  • Publication number: 20030064496
    Abstract: Isolated nucleic acid molecules encoding human MEKK2, and isolated human MEKK2 proteins, are provided. The invention further provides antisense nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals carrying a human MEKK2 transgene. The invention further provides human MEKK2 fusion proteins and anti-human MEKK2 antibodies. Methods of using the human MEKK2 proteins and nucleic acid molecules of the invention are also disclosed, including methods for detecting human MEKK2 activity in a biological sample, methods of modulating human MEKK2 activity in a cell, and methods for identifying agents that modulate the activity of human MEKK2.
    Type: Application
    Filed: June 5, 2002
    Publication date: April 3, 2003
    Applicant: AtheroGenics, Inc.
    Inventors: Anne M. Whalen, Christopher K. Cook, James A. Sikorski